4 Healthcare Stock Stories to Treat the Monday Blues

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Sanofi-Aventis (NYSE:SNY): Current price $47.41

On Monday, Sanofi announced that regulators had okayed its Lyxumia, an injectable diabetes treatment, for sale in Europe. The drug is also known by its generic name, lixisenatide, and is taken once a day along with other drugs or insulin by patients who are otherwise unable to control their blood sugar levels. Lyxumia represents one of the new products the firm is banking on to bring growth back after losing several star performers to generic competition.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.


More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business